|

BBO-11818 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1

Indications

  • KRAS G12S1
  • Metastatic Non-Small Lung Cell Cancer1
  • Advanced Lung Carcinoma1
  • KRAS G12A1
  • KRAS G12V1

Los Angeles, California1 trial

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

The Angeles Clinic and Research Institute - West Los Angeles Office

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.